Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis
- 1 October 2016
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 215 (4) , 460.e1-460.e13
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China (81302266)
- Foundation of Science and Technology Department of Zhejiang Province (2012C13019-3)
- Hubei Province health and family planning scientific research project (WJ2015MB003, WJ2015Q004)
This publication has 26 references indexed in Scilit:
- Safety of hormone replacement therapy in gynaecological cancer survivorsJournal of Obstetrics and Gynaecology, 2012
- Decreasing incidence of cervical adenocarcinoma in Ontario: Is this related to improved endocervical Pap test sampling?International Journal of Cancer, 2006
- Abdominal wall metastasis of a cervical adenocarcinoma at the laparoscopic trocar insertion site after ovarian transposition: case report and review of the literatureGynecologic Oncology, 2003
- Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomyGynecologic Oncology, 2003
- Cervical cancer and use of hormonal contraceptives: a systematic reviewThe Lancet, 2003
- A Comparison of Ovarian Metastasis between Squamous Cell Carcinoma and Adenocarcinoma of the Uterine CervixGynecologic Oncology, 2001
- A Study of Risk Factors for Ovarian Metastases in Stage IB–IIIB Cervical Carcinoma and Analysis of Ovarian Function after a TranspositionGynecologic Oncology, 2001
- Use of Hormone Replacement Therapy and Adenocarcinomas and Squamous Cell Carcinomas of the Uterine CervixGynecologic Oncology, 2000
- Microscopic ovarian metastasis of the uterine cervical cancerGynecologic Oncology, 1991
- Incidence of ovarian metastasis in patients with cancer of the uterine cervixGynecologic Oncology, 1987